Skip to main content
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
60.41
-1.78 (-2.86%)
At close: Mar 6, 2026, 4:00 PM EST
60.11
-0.30 (-0.50%)
After-hours: Mar 6, 2026, 7:59 PM EST

Cytokinetics Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Milestone
33.50M - - - 19.50M - - - 9.50M - - 11.00M - - - - - - - - -
Research and Development
8.69M 7.86M 6.39M 4.22M 3.47M 2.22M 2.13M 2.75M
Research and Development Growth
150.03% 254.12% 199.20% 53.27% -13.80% -58.25% -71.36% -63.56%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.